Covivio (EPA:COV)

G1 Therapeutics Revenue

Covivio had revenue of 564.50M EUR in the half year ending June 30, 2025, with 12.34% growth. This brings the company's revenue in the last twelve months to 1.14B, up 7.14% year-over-year. In the year 2024, Covivio had annual revenue of 1.12B with 9.77% growth.

• Revenue (ttm): 1.14B
• Revenue Growth: +7.14%
• P/S Ratio: 5.74
• Revenue / Employee: 1.19M
• Employees: 989
• Market Cap: 6.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.12B	99.60M	9.77%
Dec 31, 2023	1.02B	-48.69M	-4.56%
Dec 31, 2022	1.07B	101.62M	10.51%
Dec 31, 2021	966.68M	43.88M	4.75%
Dec 31, 2020	922.80M	-182.72M	-16.53%